Succinic acid amide derivatives containing phenylnaphthalene rings as well as preparation method and application thereof

A technology of alkyl and compounds, applied in the field of uric acid transporter 1 inhibitors, can solve problems such as allopurinol liver and bone marrow toxicity, fulminant hepatitis, and allergic reactions

Inactive Publication Date: 2015-01-21
崔玲玲
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These drugs have different degrees of toxic and side effects, such as benzbromarone has the risk of causing fulminant hepatitis, allopurinol has adverse reactions such as liver and bone marrow toxicity and allergic reactions, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Succinic acid amide derivatives containing phenylnaphthalene rings as well as preparation method and application thereof
  • Succinic acid amide derivatives containing phenylnaphthalene rings as well as preparation method and application thereof
  • Succinic acid amide derivatives containing phenylnaphthalene rings as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] .

[0030] A. Compounds IV-1 Synthesis

[0031] 5.06g (20 mmol) compound II-1 and 2.64 g (20 mmol) of compound III Dissolve in 50 mL of dry THF, stir under ice-water bath cooling, add 4.13 g (20 mmol) of dicyclohexylcarbodiimide (DCC) and 0.61 g (5 mmol) of 4-dimethylaminopyridine (DMAP), and then Stir at room temperature until the reaction is complete (within 12 h) as detected by TLC. The reaction mixture was poured into 300 mL of ice water, stirred, using 100 mL × 3 CH 2 Cl 2 Extract, combine the extract phases, successively wash with 100 mL of 1% dilute hydrochloric acid and 100 mL of 5% brine, and dry over anhydrous sodium sulfate. The desiccant was removed by suction filtration, the filtrate was evaporated to dryness on a rotary evaporator, and the obtained residue was purified by column chromatography to obtain compound IV-1 , white solid, ESI-MS, m / z = 390([M+Na] + ).

[0032] B. Compounds V-1 Synthesis

[0033] compound IV-1 Dissolve 5.50 ...

Embodiment 2-16

[0038] Referring to the operation steps of Example 1, the compounds listed in the following table were prepared.

[0039]

Embodiment 17

[0041] The compounds of the present invention and related compounds inhibit IC of URAT1 50The values ​​are determined in a similar manner as described in the literature (Example 12 in US2014 / 0005136). The results are listed below.

[0042] Construction of a cell line stably expressing the humanized URAT1 transporter: The humanized URAT1 gene (SLC22A112) was subcloned from the plasmid pCMV6-XL-5 (Origene) into the eukaryotic expression plasmid pCMV6 / neo (Origene). Gene sequencing confirmed that the humanized URAT1 was consistent with the information recorded in the gene bank (NM_144585.2). HEK293 human embryonic kidney cells (ATCC# CRL-1573) were cultured in EMEM tissue culture medium under 5% CO 2 and 95% air atmosphere. pCMV6 / Neo / URAT1 was transfected onto HEK293 cells using L2000 type transfection reagent (Invitrogene). After 24 hours, the transfected cells were divided into 10 cm diameter tissue culture dishes and grown for another day, after which the medium was replac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of medicines related to hyperuricemia and gouts and in particular relates to urate transporter 1 (URAT1) inhibitors of succinic acid amide structures containing phenylnaphthalene rings, a preparation method thereof, a medicine composition containing the URAT1 inhibitors and an application of the URAT1 inhibitors and the medicine composition in preparation of diabetes medicines. R<1> and R<2> in a general formula are defined in the specification.

Description

technical field [0001] The invention relates to the field of drugs related to the treatment of hyperuricemia and gout. Specifically, the present invention relates to a class of urate transporter 1 (urate transporter 1, URAT1) inhibitors, preparation methods, and methods for treating hyperuricemia and gout. Pharmaceutical compositions containing them and their use in medicine. Background technique [0002] Gout is a chronic metabolic disease characterized by hyperuricemia and pain caused by deposition of monosodium uric acid (MSU) in joints and other parts. The main reason is purine metabolism disorder and / or uric acid excretion disorder. It is estimated that there are more than 20 million gout patients worldwide. Drugs currently used to treat gout include anti-inflammatory drugs for pain relief (such as colchicine, etc.), drugs that inhibit uric acid production (xanthine oxidase inhibitors represented by allopurinol and febuxostat), crude uric acid Excretion drugs (uric a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C233/07C07C231/14A61K31/165A61P19/06
Inventor 不公告发明人
Owner 崔玲玲
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products